Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

S. Ye, G. F. Watts, S. Mandalia, S. E. Humphries, A. M. Henney

Department of Medicine, University College London Medical School.

Stromelysin is a member of the family of metalloproteinases that degrade extracellular matrix. In situ hybridisation and histopathological studies suggest that stromelysin activity may be important in the connective tissue remodelling processes associated with atherogenesis and plaque rupture. Single strand conformation polymorphism analysis identified a common polymorphism in the stromelysin gene promoter located 1171 bp upstream from the start of transcription in which one allele has a run of six adenosines (6A) and another has five adenosines (5A). 72 men with coronary heart disease, were genotyped. They were participants in the St Thomas' Atherosclerosis Regression Study who were randomised to receive usual care (UC), dietary intervention (D), or diet plus cholestyramine (DC), with angiography at baseline and at 39 months. In these patients the frequency of the 5A allele was 0.49 (95% CI from 0.41 to 0.57) and was not significantly different from that in a sample of 354 healthy UK men. In the UC group, patients who were homozygous for the 6A allele showed greater progression of angiographic disease than those with other genotypes: the minimum absolute width of coronary segments decreased by 0.04 (SEM 0.10) mm for 5A5A, 0.20 (0.07) mm for 5A6A, and 0.67 (0.19) mm for 6A6A (P < 0.01). The findings were similar but slightly less significant for the change in mean absolute width of coronary segments (P < 0.05). No significant associations were seen in patients in the D or DC groups. In data pooled from the three treatment groups, the 6A6A genotype was significantly associated with greater progression of coronary atherosclerosis than other genotypes in patients with baseline percentage diameter stenosis less than 20% (P < 0.05), but not in those with baseline percentage diameter stenosis greater than or equal to 20%. These results provide the first evidence of a link between genetic variation in stromelysin and progression of coronary atherosclerosis and support the hypothesis that connective tissue remodeling mediated by metalloproteinases contribute to the pathogenesis of atherosclerosis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Cozzolino, M., Biondi, M. L., Galassi, A., Turri, O., Brancaccio, D., Gallieni, M. (2009). Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients. Nephrol Dial Transplant 24: 2207-2212 [Abstract] [Full Text]  
• Beeghly-Fadiel, A., Xiang, Y.-B., Deming, S. L., Long, J.-R., Xu, W.-H., Cai, Q., Zheng, W., Shu, X. O. (2009). No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 18: 1925-1928 [Full Text]  
• Beeghly-Fadiel, A., Cai, Q., Lu, W., Long, J., Gao, Y.-T., Shu, X.-o., Zheng, W. (2009). No Association between Matrix Metalloproteinase-1 or Matrix Metalloproteinase-3 Polymorphisms and Breast Cancer Susceptibility: A Report from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev. 18: 1324-1327 [Full Text]  
• Hadjipavlou, A. G., Tzermiadianos, M. N., Bogduk, N., Zindrick, M. R. (2008). The pathophysiology of disc degeneration: A CRITICAL REVIEW. J Bone Joint Surg Br 90-B: 1261-1270 [Abstract] [Full Text]  
• Iakoubova, O. A., Tong, C. H., Rowland, C. M., Kirchgessner, T. G., Young, B. A., Arellano, A. R., Shiffman, D., Sabatine, M. S., Campos, H., Packard, C. J., Pfeffer, M. A., White, T. J., Braunwald, E., Shepherd, J., Devlin, J. J., Sacks, F. M. (2008). Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.. J Am Coll Cardiol 51: 435-443 [Abstract] [Full Text]  
• White, A. J., Duffy, S. J., Walton, A. S., Ng, J. F., Rice, G. E., Mukherjee, S., Shaw, J. A., Jennings, G. L., Dart, A. M., Kingwell, B. A. (2007). Matrix metalloproteinase-3 and coronary remodelling: Implications for unstable coronary disease. Cardiovasc Res 75: 813-820 [Abstract] [Full Text]  
• Abilleira, S., Bevan, S., Markus, H. S (2006). The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J. Med. Genet. 43: 897-901 [Abstract] [Full Text]  
• Dollery, C. M., Libby, P. (2006). Atherosclerosis and proteinase activation. Cardiovasc Res 69: 625-635 [Abstract] [Full Text]  
• Ye, S. (2006). Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 69: 636-645 [Abstract] [Full Text]  
• Achneck, H., Modi, B., Shaw, C., Rizzo, J., Albornoz, G., Fusco, D., Elefteriades, J. (2005). Ascending Thoracic Aneurysms Are Associated With Decreased Systemic Atherosclerosis. Chest 128: 1580-1586 [Abstract] [Full Text]  
• Shan, K., Ying, W., Jian-Hui, Z., Wei, G., Na, W., Yan, L. (2005). The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Mol Hum Reprod 11: 423-427 [Abstract] [Full Text]  
• Fang, S., Jin, X., Wang, R., Li, Y., Guo, W., Wang, N., Wang, Y., Wen, D., Wei, L., Zhang, J. (2005). Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26: 481-486 [Abstract] [Full Text]  
• Zinzindohoue, F., Lecomte, T., Ferraz, J.-M., Houllier, A.-M., Cugnenc, P.-H., Berger, A., Blons, H., Laurent-Puig, P. (2005). Prognostic Significance of MMP-1 and MMP-3 Functional Promoter Polymorphisms in Colorectal Cancer. Clin. Cancer Res. 11: 594-599 [Abstract] [Full Text]  
• Newby, A. C. (2005). Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture. Physiol. Rev. 85: 1-31 [Abstract] [Full Text]  
• Jin, L., Weisman, M., Zhang, G., Ward, M., Luo, J., Bruckel, J., Inman, R., Khan, M. A., Schumacher, H. R., Maksymowych, W. P., Mahowald, M., Martin, T., Rosenbaum, J. T., Yu, D. T. Y., Stone, M., Watson, J., Dickman, E., Davis, J., Reveille, J. D. (2005). Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity. Rheumatology (Oxford) 44: 55-60 [Abstract] [Full Text]  
• Zhang, J., Jin, X., Fang, S., Li, Y., Wang, R., Guo, W., Wang, N., Wang, Y., Wen, D., Wei, L., Kuang, G., Dong, Z. (2004). The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 25: 2519-2524 [Abstract] [Full Text]  
• Pender, S L F, Croucher, P J P, Mascheretti, S, Prothero, J D, Fisher, S A, MacDonald, T T, Schreiber, S, Ye, S. (2004). Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn's disease. J. Med. Genet. 41: e112-e112 [Full Text]  
• Liu, J., Sukhova, G. K., Sun, J.-S., Xu, W.-H., Libby, P., Shi, G.-P. (2004). Lysosomal Cysteine Proteases in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 24: 1359-1366 [Abstract] [Full Text]  
• Murase, Y., Yamada, Y., Hirashiki, A., Ichihara, S., Kanda, H., Watarai, M., Takatsu, F., Murohara, T., Yokota, M. (2004). Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 25: 970-977 [Abstract] [Full Text]  
• Hoppmann, P., Koch, W., Schomig, A., Kastrati, A. (2004). The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. Eur Heart J 25: 335-341 [Abstract] [Full Text]  
• Noponen-Hietala, N, Kyllonen, E, Mannikko, M, Ilkko, E, Karppinen, J, Ott, J, Ala-Kokko, L (2003). Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis. Ann Rheum Dis 62: 1208-1214 [Abstract] [Full Text]  
• Hirashiki, A., Yamada, Y., Murase, Y., Suzuki, Y., Kataoka, H., Morimoto, Y., Tajika, T., Murohara, T., Yokota, M. (2003). Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 42: 1429-1437 [Abstract] [Full Text]  
• Beyzade, S., Zhang, S., Wong, Y.-k., Day, I. N. M., Eriksson, P., Ye, S. (2003). Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 41: 2130-2137 [Abstract] [Full Text]  
• Medley, T. L., Kingwell, B. A., Gatzka, C. D., Pillay, P., Cole, T. J. (2003). Matrix Metalloproteinase-3 Genotype Contributes to Age-Related Aortic Stiffening Through Modulation of Gene and Protein Expression. Circ. Res. 92: 1254-1261 [Abstract] [Full Text]  
• Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., Yokota, M. (2002). Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes. NEJM 347: 1916-1923 [Abstract] [Full Text]  
• Ghilardi, G., Biondi, M. L., Caputo, M., Leviti, S., DeMonti, M., Guagnellini, E., Scorza, R. (2002). A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-3 Promoter Enhances Breast Cancer Susceptibility. Clin. Cancer Res. 8: 3820-3823 [Abstract] [Full Text]  
• Ghilardi, G., Biondi, M. L., DeMonti, M., Turri, O., Guagnellini, E., Scorza, R. (2002). Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Promoter Polymorphisms Are Associated With Carotid Artery Stenosis. Stroke 33: 2408-2412 [Abstract] [Full Text]  
• Lamblin, N., Bauters, C., Hermant, X., Lablanche, J.-M., Helbecque, N., Amouyel, P. (2002). Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 40: 43-48 [Abstract] [Full Text]  
• Taegtmeyer, A.B., Barton, P.J.R. (2002). SNP at your own risk. Eur Heart J 23: 692-694 [Full Text]  
• Humphries, S., Bauters, C., Meirhaeghe, A., Luong, L., Bertrand, M., Amouyel, P. (2002). The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J 23: 721-725 [Abstract] [Full Text]  
• Loftus, I., Thompson, M. (2002). The role of matrix metalloproteinases in vascular disease. Vasc Med 7: 117-133 [Abstract]  
• Rundek, T., Elkind, M. S., Pittman, J., Boden-Albala, B., Martin, S., Humphries, S. E., Juo, S.-H. H., Sacco, R. L. (2002). Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase Genes: The Northern Manhattan Prospective Cohort Study. Stroke 33: 1420-1423 [Abstract] [Full Text]  
• Galis, Z. S., Khatri, J. J. (2002). Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly. Circ. Res. 90: 251-262 [Abstract] [Full Text]  
• Lamblin, N., Bauters, C., Helbecque, N. (2001). Gene polymorphisms of pro- (or anti-) inflammatory cytokines and vascular disease. Eur Heart J 22: 2219-2220  
• Agema, W. R. P., Jukema, J. W., Pimstone, S. N., Kastelein, J. J. P. (2001). Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy. Eur Heart J 22: 2058-2074  
• Zhang, B., Dhillon, S., Geary, I., Howell, W. M., Iannotti, F., Day, I. N.M., Ye, S. (2001). Polymorphisms in Matrix Metalloproteinase-1, -3, -9, and -12 Genes in Relation to Subarachnoid Hemorrhage. Stroke 32: 2198-2202 [Abstract] [Full Text]  
• Marasini, B., Casari, S., Zeni, S., Turri, O., Biondi, M. L. (2001). Stromelysin promoter polymorphism is associated with systemic sclerosis. Rheumatology (Oxford) 40: 475-476 [Full Text]  
• Rauramaa, R., Vaisanen, S. B., Luong, L.-A., Schmidt-Trucksass, A., Penttila, I. M., Bouchard, C., Toyry, J., Humphries, S. E. (2000). Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 20: 2657-2662 [Abstract] [Full Text]  
• Gnasso, A., Motti, C., Irace, C., Carallo, C., Liberatoscioli, L., Bernardini, S., Massoud, R., Mattioli, P. L., Federici, G., Cortese, C. (2000). Genetic Variation in Human Stromelysin Gene Promoter and Common Carotid Geometry in Healthy Male Subjects. Arterioscler. Thromb. Vasc. Bio. 20: 1600-1605 [Abstract] [Full Text]  
• Loftus, I. M., Naylor, A. R., Goodall, S., Crowther, M., Jones, L., Bell, P. R. F., Thompson, M. M. (2000). Increased Matrix Metalloproteinase-9 Activity in Unstable Carotid Plaques : A Potential Role in Acute Plaque Disruption. Stroke 31: 40-47 [Abstract] [Full Text]  
• Terashima, M., Akita, H., Kanazawa, K., Inoue, N., Yamada, S., Ito, K., Matsuda, Y., Takai, E., Iwai, C., Kurogane, H., Yoshida, Y., Yokoyama, M. (1999). Stromelysin Promoter 5A/6A Polymorphism Is Associated With Acute Myocardial Infarction. Circulation 99: 2717-2719 [Abstract] [Full Text]  
• Barnes, P. J (1999). Genetics and pulmonary medicine bullet  9: Molecular genetics of chronic obstructive pulmonary disease. Thorax 54: 245-252 [Full Text]  
• Borghaei, R. C., Sullivan, C., Mochan, E. (1999). Identification of a Cytokine-induced Repressor of Interleukin-1 Stimulated Expression of Stromelysin 1 (MMP-3). J. Biol. Chem. 274: 2126-2131 [Abstract] [Full Text]  
• Webb, K. E., Henney, A. M., Anglin, S., Humphries, S. E., McEwan, J. R. (1997). Expression of Matrix Metalloproteinases and Their Inhibitor TIMP-1 in the Rat Carotid Artery After Balloon Injury. Arterioscler. Thromb. Vasc. Bio. 17: 1837-1844 [Abstract] [Full Text]  
• Ye, S., Eriksson, P., Hamsten, A., Kurkinen, M., Humphries, S. E., Henney, A. M. (1996). Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression. J. Biol. Chem. 271: 13055-13060 [Abstract] [Full Text]  
• Dollery, C. M., McEwan, J. R., Henney, A. M. (1995). Matrix Metalloproteinases and Cardiovascular Disease. Circ. Res. 77: 863-868 [Full Text]